Ppe Net - Calithera Biosciences Inc (F:2CB) - Alpha Spread
C

Calithera Biosciences Inc
F:2CB

Watchlist Manager
Calithera Biosciences Inc
F:2CB
Watchlist
Price: 3.86 EUR -2.53% Market Closed
Market Cap: 1m EUR
Have any thoughts about
Calithera Biosciences Inc?
Write Note

Calithera Biosciences Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Calithera Biosciences Inc
PP&E Net Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
C
Calithera Biosciences Inc
F:2CB
PP&E Net
$1.8m
CAGR 3-Years
-40%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
PP&E Net
$5B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Net
$5.3B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
14%
Amgen Inc
NASDAQ:AMGN
PP&E Net
$6.1B
CAGR 3-Years
8%
CAGR 5-Years
3%
CAGR 10-Years
1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Net
$1.8B
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
9%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Net
$4.3B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
20%

See Also

What is Calithera Biosciences Inc's PP&E Net?
PP&E Net
1.8m USD

Based on the financial report for Dec 31, 2022, Calithera Biosciences Inc's PP&E Net amounts to 1.8m USD.

What is Calithera Biosciences Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
0%

Over the last year, the PP&E Net growth was -40%. The average annual PP&E Net growth rates for Calithera Biosciences Inc have been -40% over the past three years .

Back to Top